We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Regeneron Pharmaceuticals has begun a phase 3 clinical trial in the U.S. of its antibody cocktail REGN-COV2 for the prevention of COVID-19 infections. Read More
The parallel use of human challenge trials and large-scale conventional trials could help accelerate the development of an effective vaccine for COVID-19, NIH vaccine experts say. Read More
Sanofi and Regeneron Pharmaceuticals have stopped a phase 3 clinical trial in the U.S. of their rheumatoid arthritis drug Kevzara (sarilumab) as a COVID-19 treatment after it failed to meet its primary endpoints. Read More
Inovio Pharmaceuticals has released data from the phase 1 clinical trial of its COVID-19 vaccine candidate showing it was safe and well-tolerated and induced immune responses in a majority of participants. Read More
The University of Oxford is resuming recruitment this week for its global clinical trial of hydroxychloroquine and chloroquine, which was paused after a now-retracted study found the antimalarial drugs had no benefit as a treatment for COVID-19. Read More